Werewolf Therapeutics, Inc.
NASDAQ:HOWLBiotechnology
Healthcare
$1.03 +6.12%
+$0.06 today
- Market cap
- $50.06M
- Beta
- 0.29
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$0.71
52W Low $0.27High $1.83
Volume 1.85M
Average 5.09M
Price history
Werewolf Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+11.39%
Period high
$1.10
Period low
$0.31
Latest
$1.03
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 16, 2026 | Nov 16, 2026 | |
| 10-Q | Nov 13, 2026 | Nov 13, 2026 | |
| 424B3 | Nov 12, 2026 | Nov 12, 2026 | |
| EFFECT | Nov 12, 2026 | Nov 13, 2026 | |
| S-4/A | Nov 10, 2026 | Nov 10, 2026 | |
| 425 | Nov 10, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| S-4/A | Oct 26, 2026 | Oct 26, 2026 | |
| S-4 | Sep 22, 2026 | Sep 22, 2026 | |
| SC 13G | Sep 21, 2026 | Sep 21, 2026 | |
| 425 | Aug 21, 2026 | Aug 21, 2026 | |
| 8-K | Aug 21, 2026 | Aug 21, 2026 | |
| 8-K | Aug 20, 2026 | Aug 20, 2026 | |
| 10-Q | Jul 31, 2026 | Jul 31, 2026 | |
| 8-K | Jul 31, 2026 | Jul 31, 2026 |
Competitors
Who does Werewolf Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about HOWL's filings, answered from its disclosures.
What is the latest HOWL filing?
The latest filing shown is SC 13G dated Nov 16, 2026.
How many recent filings does HOWL have?
Intrinsic Alpha currently shows 20 recent filings for HOWL.
Continue the stock analysis
Jump to another research area for this company.